Skip to main content
. 2025 Sep 10;17(18):2967. doi: 10.3390/cancers17182967
NSCLC Non-Small Cell Lung Cancer
IQR Interquartile range
ICIs Immune Checkpoint Inhibitors
pCR Complete Pathological Response
MPR Major Pathological Response
PFS Progression-Free Survival
OS Overall Survival
CT Computed Tomography
18 F FDG PET 18 fluorodeoxyglucose positron emission tomography
MRI Magnetic Resonance Imaging
EBUS Endobronchial ultrasound
ESTS European Society of Thoracic Surgery
PD-L1 Programmed Cell Death Ligand 1
TNM Tumor Node Metastasis
MTB Multidisciplinary Tumor Board
HER 2
SBRT
Human epidermal growth factor receptor 2
Stereotactic body radiation therapy
VATS Video-assisted thoracoscopic surgery
IASCL International Association for the Study of Lung Cancer
BMI Body Mass Index
CTCAE Common Terminology Criteria for Adverse Events
CEAVNO Comitato Etico Regione Toscana-Area Vasta Nord Ovest
SPSS Statistical Package for the Social Sciences
SD Standard Deviation
ECOG-PS
COPD
OSAS
FEV1
FVC
DLCO
Eastern Cooperative Oncology Group Performance Status
Chronic Obstructive Pulmonary Disease
Obstructive Sleep Apnea Syndrome
Forced Expiratory Volume in 1 s
Forced Vital Capacity
Diffusing capacity for carbon monoxide
OR Odd Ratio
SE Standard error
CI Confidence Interval
RUL Right Upper Lobe
RLL Right Lower Lobe
RML Right Middle Lobe
LUL Left Upper Lobe
LLL Left Lower Lobe